Knee Osteoarthritis Market Size
Market Size in USD Bn
CAGR12.7%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 12.7% |
| Market Concentration | High |
| Major Players | Anika Therapeutics, Bioventus, Sanofi/Genzyme, Taiwan Liposome Company (TLC599), Centrexion Therapeutics (CNTX-4975) and Among Others |
please let us know !
Knee Osteoarthritis Market Analysis
The knee osteoarthritis market is estimated to be valued at USD 13.19 Bn in 2025 and is expected to reach USD 30.46 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.7% from 2025 to 2032. The aging population prone to knee issues along with growing obesity rates globally is expected to drive the demand for knee osteoarthritis treatments over the forecast period.
The knee osteoarthritis market is expected to grow significantly due to the rising geriatric population worldwide and the associated increase in the prevalence of osteoarthritis. Moreover, the development and approval of novel drug classes for osteoarthritis treatment such as Intra-articular tranexamic acid are expected to provide opportunities for market growth between 2025-2032.